Day: April 2, 2020

SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) — La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced that it is providing GIAPREZA™ (angiotensin II) for named patient emergency use in patients with septic shock due to COVID-19 at Guy’s and St Thomas’ NHS Foundation Trust in London, United Kingdom. GIAPREZA is being made available for named patient emergency use based on a request from Marlies Ostermann, M.D., Consultant in Nephrology and Critical Care at Guy’s and St. Thomas’ NHS Foundation Trust, London, England. According to English law, authorized medicines can be made available prior to commercial availability in order to fulfill special patient needs. GIAPREZA...

SOUTH SAN FRANCISCO, Calif., April 02, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Fluidigm® CyTOF® technology was used in a clinical study producing preliminary evidence that mesenchymal stem cell (MSC) therapy improves outcomes in patients with COVID-19 pneumonia, providing key information about potential mechanisms of action of the treatment strategy.Results of the study, conducted by researchers in China, have been published in Aging and Disease.1“We used a 36-marker CyTOF panel to generate a broad immune profile of each patient’s peripheral blood before and after transplantation,” said Wenjing Wang, PhD, Associate Professor at Beijing Hepatology Research Institute, You’an Hospital....

NORCROSS, Ga., April 02, 2020 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins today provided an update on the impact of the COVID-19 pandemic on the Company and its clinical trial activities.As the global COVID-19 pandemic continues to quickly evolve, we have put measures in place intended to safeguard the health of our employees in line with many other companies. In doing so, we aim to do our part to help slow the spread of COVID-19 in our communities and protect our employees and their families, all while continuing the critical work necessary to initiate and conduct our NASH-RX clinical trial for patients with NASH cirrhosis. In accordance with guidance issued by the Centers for Disease Control and Prevention (CDC), the World Health Organization...

San Francisco, CA, April 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the fourth quarter and twelve months ended December 31, 2019.Fourth Quarter 2019 HighlightsTotal revenue in the fourth quarter was $4,786,000, consistent with the comparable period in 2018.  Proton therapy revenue of $1,486,000 increased 4.7% from the fourth quarter of 2018.  Gamma Knife revenue of $3,230,000 increased 4.1% quarter over quarter due to higher volumes at existing sites.Total proton therapy fractions in the fourth quarter increased 4.3% quarter over quarter.  The increase for the fourth quarter was due to higher...

Copenhagen, April 02, 2020 (GLOBE NEWSWIRE) —Ovennævnte forening har afholdt ordinær generalforsamling torsdag den 2. april 2020.Investorerne kan forvente at have udbyttet til rådighed den 7. april 2020.Forslag om endelig likvidation af investeringsforeningenForslaget blev vedtaget enstemmigt.på vegne afInvesteringsforeningen Nielsen Global Value i likvidationc/o BI Management A/SSundkrogsgade 72100 København Ø

HOUSTON, April 02, 2020 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) today announced that it will kick off a month-long social media campaign, Take Out To Give Back, in conjunction with No Kid Hungry in order to provide healthy and nutritious meals in underserved communities while promoting the restaurant industry during the COVID-19 global pandemic.  The campaign encourages the public to:Order food to-go, for delivery, or through a gift card purchase;Post photos of their purchases on social media;Use the hashtags #takeouttogiveback and #nokidhungry;Tag the restaurant in the post.For every post, Sysco will donate 50 cents up to $150,000 to No Kid Hungry, a campaign run by Share Our Strength, a non-profit working to solve problems of hunger and poverty in the U.S. and around the world.“Food is our business and our passion and...

TORONTO, April 02, 2020 (GLOBE NEWSWIRE) — YANGAROO Inc. (TSX-V:YOO, OTBB:YOOIF, the “Company”), the software leader in work flow management and media distribution solutions, today announces the signing of a multiyear renewal with The Latin Recording Academy®, the organization behind the Latin GRAMMY Awards®. YANGAROO will continue to provide its digital awards management platform that streamlines every aspect of awards-show management.“YANGAROO has been a strong and dependable partner for many years now, and we are thrilled to extend the relationship,” said Luis Dousdebes, Chief Awards, Membership & Preservation Officer of The Latin Recording Academy. “We look forward to continuing a productive and beneficial partnership.”“This marks another long-term commitment between The Latin Recording Academy® and YANGAROO”, said...

SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) — Crown Bioscience today announced the strategic expansion of their PDX collection through new agreements with CoMotion at the University of Washington and Dana-Farber Cancer Institute. These agreements will provide highly needed prostate cancer and lymphoma models, respectively, to the oncology drug development community.PDX models are the most translatable preclinical in vivo models currently available and are the model of choice for preclinical oncology drug discovery and development. However, certain PDXs can be difficult to derive from specific indications, including prostate cancer, while other clinically relevant mutations are underrepresented within current PDX collections.CrownBio’s license with CoMotion at the University of Washington will significantly expand the number of prostate...